Filgrastim Recruiting Phase 2 Trials for Retinoblastoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01783535Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma